Kliniken Nordoberpfalz AG

Weiden, Bavaria 92637

0 studies enrolling now · 2 studies all time

What they study most

Gastric Adenocarcinoma, Neoplasm Metastasis, Urinary Bladder Neoplasm

Studies at this site

• A Single-Arm Study of Bempegaldesleukin (NKTR-214) Plus Nivolumab in Cisplatin Ineligible Patients Who Have Locally Advanced or Metastatic Urothelial Cancer — Completed
• Andecaliximab With mFOLFOX6 as First Line Treatment for Advanced Gastric or Gastroesophageal Junction Adenocarcinoma — Completed